Nevertheless, reversal of M2-like polarization in experimental HCC has yielded promising results in containing tumor progression (240) with TIM-3 and Wnt ligands identified as critical drivers of alternative activation of TAMs and HCC growth (239, 241). The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.